From WisPolitics.com/WisBusiness.com …
— A Madison-based company called Atrility Medical is developing an AI platform for improved cardiac patient monitoring, based on data from its FDA-cleared AtriAmp device.
Rather than connecting to surface leads like other heartbeat monitoring devices, the device connects to wires that are placed on the patient’s heart during open-heart surgery. It can display signals from the heart on a bedside monitor, providing “rich detail” that can’t be seen from standard surface leads.
That’s according to CEO Dr. Sean McCormick, who presented the company last week during the Greater Madison Chamber of Commerce’s Pressure Chamber pitch competition, held as part of Forward Fest.
The more in-depth data from the company’s device is key for diagnosing arrhythmias, or abnormal heartbeats, he explained.
“Now we’re using our patented device with this rich data to create a one-of-a-kind database in which we’re building software and AI models that will take us far beyond the ICU,” he said.
The AtriAmp is already being used in pediatric hospitals around the country, and is being trialed in adult intensive care units as well, he said. The devices have collected more than 300,000 hours of cardiac waveform data.
Starting next summer, the company plans to release the first version of its software built with this information, aimed at helping care teams intervene more quickly in cases of arrhythmia. Using its predictive algorithm, the platform can provide up to 12 hours of lead time for a coming arrhythmia, according to McCormick.
“Essentially, our data is so good, we can detect subtle variations in the waveform that can spiral out of control and turn into an arrhythmia downstream,” he said. “This will allow the care team to prevent that arrhythmia, improving clinical outcomes, reducing total cost of care and shortening the all-important length of stay in the ICU.”
Using the AtriAmp waveform data alongside standard surface lead data, the company will teach its AI to “pick out subtle but critical” elements of the heart signal. Along with better identification of arrhythmias for all cardiac patients — not just those with atrial wires — the system can also reduce the “frequent over-alarming,” McCormick says, helping to address provider burnout.
The business expects to hit $1 million in revenue by next year, he said.
See coverage of Pressure Chamber and more from Forward Fest.
Top Stories
– An Insurer Agreed To Cover Her Surgery. A Politician’s Nudge Got the Bills Paid.
– Lilly pill cuts body weight by 10.5% in patients with type 2 diabetes
– Blue States That Sued Kept Most CDC Grants, While Red States Feel Brunt of Trump Clawbacks
– Cities Move Away From Strategies That Make Drug Use Safer
– Regeneron’s immune disorder therapy improves daily functions in trial
– Pig Lung Transplanted Into Man for 9 Days in Groundbreaking Study
Press Releases
– Marquette University: Names Advocate Health leader Troy Dennhof vice president for human resources
